andrew huberman semaglutide on Retatrutide: What He Said and What the Data Shows If you're on or considering

If youre taking a GLP-1, you need to be able to discern the difference between standard side effects and something that may require medical attention

Impact of osteoporosis and osteoporosis medications on fracture healing: A narrative review

Rybelsus is a GLP-1 (glucagon-like-peptide-1) medication with the active ingredient, semaglutide, FDA-approved to help lower blood sugar levels in adults with type 2 diabetes

Non-steroidal anti-inflammatory drugs (NSAIDs), statins, glucocorticoids and monoclonal antibodies (e.g., targeting IL-6, TNF-, IL-12/23) have been reported to show moderate anti-depressant capacity in patients with somatic disorders (i.e., rheumatoid arthritis, psoriasis) who also had comorbid symptoms of depression [194, 195]

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach